UBS Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.59M | Buy |
|
|||||
|
2025
Q1 | $349K | Sell |
|
|||||
|
2024
Q4 | $244K | Buy |
|
|||||
|
2024
Q3 | $170K | Sell |
|
|||||
|
2024
Q2 | $584K | Buy |
|
|||||
|
2024
Q1 | $309K | Sell |
|
|||||
|
2023
Q4 | $207K | Buy |
|
|||||
|
2023
Q3 | $65K | Sell |
|
|||||
|
2023
Q2 | $80.1K | Buy |
|
|||||
|
2023
Q1 | $84.2K | Buy |
|
|||||
|
2022
Q4 | $92.2K | Sell |
|
|||||
|
2022
Q3 | $372K | Buy |
|
|||||
|
2022
Q2 | $22K | Sell |
|
|||||
|
2022
Q1 | $1.34M | Sell |
|
|||||
|
2021
Q4 | $2.92M | Buy |
|
|||||
|
2021
Q3 | $2.65M | Buy |
|
|||||
|
2021
Q2 | $126K | Sell |
|
|||||
|
2021
Q1 | $2.4M | Buy |
|
|||||
|
2020
Q4 | $2.78M | Buy |
|
|||||
|
2020
Q3 | $1.36M | Sell |
|
|||||
|
2020
Q2 | $1.68M | Sell |
|
|||||
|
2020
Q1 | $1.47M | Buy |
|
|||||
|
2019
Q4 | $2.31M | Sell |
|
|||||
|
2019
Q3 | $4.46M | Buy |
|
|||||
|
2019
Q2 | $3.34M | Buy |
|
|||||
|
2019
Q1 | $1.39M | Sell |
|
|||||
|
2018
Q4 | $5.33M | Buy |
|
|||||
|
2018
Q3 | $2.75M | Buy |
|
|||||
|
2018
Q2 | $2.01M | Sell |
|
|||||
|
2018
Q1 | $6.04M | Buy |
|
|||||
|
2017
Q4 | $714K | Sell |
|
|||||
|
2017
Q3 | $734K | Buy |
|
|||||
|
2017
Q2 | $423K | Buy |
|
|||||
|
2017
Q1 | $173K | Sell |
|
|||||
|
2016
Q4 | $585K | Buy |
|
|||||
|
2016
Q3 | $155K | Sell |
|
|||||
|
2016
Q2 | $3.72M | Buy |
|
|||||
|
2016
Q1 | $2.65M | Sell |
|
|||||
|
2015
Q4 | $9.38M | Buy |
|
|||||
|
2015
Q3 | $7.59M | Buy |
|
|||||
|
2015
Q2 | $7.51M | Buy |
|
|||||
|
2015
Q1 | $21K | Sell |
|
|||||
|
2014
Q4 | $16K | Buy |
|